Literature DB >> 11594940

Does mild cognitive impairment represent early-stage Alzheimer disease?

P T Akins.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11594940     DOI： 10.1001/archneur.58.10.1705-a

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  1 in total

1.  Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.

Authors:  Miguel J A Láinez; Jean Schoenen; Chad Stroud; Jennifer Bardos; Mark Bangs; Phebe Kemmer; Richard Wenzel; Dulanji K Kuruppu; James Michael Martinez; Tina M Oakes
Journal:  Headache       Date:  2021-11-22       Impact factor: 5.311
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.